avelumab,carfilzomib,dexamethasone,lenalidomide,Daratumumab
amgen,pfizer,merck,Janssen
[' lena', 'mmsm', 'lenalidomide', 'krd', ' ave ', 'dexamethasone', 'carfilzomib']
beautiful work by on genomic determinants of resistance to upfront dkrd in the manhattan trial. new somatic events include ikfz3 focal deletions as a resistance mechanism to imids #ash22 #mmsm 
MD PhD, Specialized in Multiple Myeloma. Memorial Sloan Kettering Cancer Center. Karolinska Institute. Tweets are my own.